生物晶片市场按产品类型、最终用户和地区划分

2025 年全球生物晶片市场规模估计为 133.4 亿美元，预计到 2032 年将达到 377.3 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 16.0%。

数字。 2025年生物晶片市场占有率（按地区）

全球生物晶片市场包括用于检测和识别生物分子的技术，包括病原体和基因到蛋白质和 DNA 序列。生物晶片用于药物研发、疾病诊断、食品安全等领域。政府和私人组织不断增加的研发力度和资金投入正在推动创新生物感测器技术的市场发展。分子生物学领域的进步和精准医疗的兴起正在加速各产业对生物晶片的应用。生物晶片设计和製造流程的改进很可能在不久的将来提供有利可图的成长机会。

市场动态：

全球生物晶片市场的成长受到癌症等疾病日益流行的推动以及对早期诊断的关注。生物技术和生命科学研究投资的不断增加也推动了对生物晶片的需求，生物晶片可以在微观层面检测生物分子的相互作用。然而，生物晶片的开发成本很高，而且严格的监管标准可能会延迟产品核准。缺乏熟练的专业人员阻碍了生物晶片的广泛应用。开发中国家提供了尚未开发的商机。微阵列和微流体技术的出现提高了生物晶片的检测能力，将其应用领域从医疗保健扩展到环境监测和食品安全检测。

本研究的主要特点

本报告对全球生物晶片市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模（以十亿美元为单位）和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。

全球生物晶片市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。

主要公司包括 Illumina、Thermo Fisher Scientific Inc.、Agilent Technologies、Bio-Rad Laboratories Inc.、PerkinElmer Inc.、Fluidigm Corporation 和 GE Healthcare。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球生物晶片市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。

相关人员将透过用于分析全球生物晶片市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管情景
• 收购与合作场景
• 资金筹措与投资
• PEST分析
• 波特的分析

第四章 全球生物晶片市场-冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020-2032 年全球生物晶片市场（按产品类型划分）（十亿美元）

• DNA晶片
• 癌症诊断与治疗
• 基因表现
• SNP基因型鉴定
• 基因组学
• 药物研发
• 农业生物技术
• 其他的
• 蛋白质晶片
• 蛋白质体学
• 表达谱分析
• 诊断
• HTS
• 其他的
• 实验室晶片
• IVD和POC
• 其他的
• 组织阵列
• 细胞阵列

6. 2020-2032 年全球生物晶片市场（以最终用户划分）（十亿美元）

• 生物技术和製药公司
• 学术研究所
• 医院和诊断中心
• 其他的

7. 2020-2032年全球生物晶片市场（按地区划分）（单位：十亿美元）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章竞争格局

• 公司简介
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Fluidigm Corporation
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Standard BioTools
  • GE Healthcare
  • F. Hoffmann-La Roche AG
  • QIAGEN
  • Randox Laboratories Ltd
  • LI-COR, Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • Arrayit Corporation
  • Nanostring Technologies, Inc.
  • GnuBio, Inc.

第九章分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十章参考文献与调查方法

• 参考
• 调查方法

Global Biochips Market is estimated to be valued at USD 13.34 Bn in 2025 and is expected to reach USD 37.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.0% from 2025 to 2032.

Figure. Biochips Market Share (%), By Region 2025

Global biochips market consists of technology used for detecting and identifying biological molecules from pathogens and genes to proteins and DNA sequences. Biochips are used in drug discovery, disease diagnosis, and food safety, among others. Increasing R&D efforts and funding from governments and private organizations for developing innovative biosensor technologies can drive the market growth. Advancements in fields of molecular biology and rise of precision medicine have accelerated the adoption of biochips across industries. Enhancements in biochip design and manufacturing processes can offer lucrative growth opportunities in the near future.

Market Dynamics:

Global biochips market growth is driven by rising prevalence of diseases like cancer and focus on early diagnosis. Growing investments in biotechnology and life science research also boosts demand for biochips to detect biomolecular interactions at microscopic levels. However, high costs associated with biochip development and strict regulatory norms can delay product approvals. Lack of skilled professionals can hamper its wider adoption. Untapped opportunities in developing nations present lucrative prospects. Emergence of microarray and microfluidic technology have improved detection capacities of biochips, thus, expanding application areas from healthcare to environmental monitoring and food safety testing.

Key features of the study:

This report provides in-depth analysis of the global biochips market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global biochips market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories Inc., PerkinElmer Inc., Fluidigm Corporation, and GE Healthcare

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global biochips market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biochips market

Detailed Segmentation-

• By Product Type
  • DNA Chips
  • Cancer Diagnosis and Treatment
  • Gene Expression
  • SNP Genotyping
  • Genomics
  • Drug Discovery
  • Agricultural Biotechnology
  • Others
  • Protein Chips
  • Proteomics
  • Expression Profiling
  • Diagnostics
  • HTS
  • Others
  • Lab-on-chip
  • IVD & POC
  • Others
  • Tissue Arrays
  • Cell Arrays
• By End User
  • Biotechnology and Pharmaceutical Companies
  • Academic & Research Institutes
  • Hospitals and Diagnostic Centers
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Fluidigm Corporation
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Standard BioTools
  • GE Healthcare
  • Hoffmann-La Roche AG
  • QIAGEN
  • Randox Laboratories Ltd
  • LI-COR, Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • Arrayit Corporation
  • Nanostring Technologies, Inc.
  • GnuBio, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Biochips Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Biochips Market, By Product Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• DNA Chips
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cancer Diagnosis and Treatment
• Gene Expression
• SNP Genotyping
• Genomics
• Drug Discovery
• Agricultural Biotechnology
• Others
• Protein Chips
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Proteomics
• Expression Profiling
• Diagnostics
• HTS
• Others
• Lab-on-chip
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• IVD & POC
• Others
• Tissue Arrays
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cell Arrays
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Biochips Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Biotechnology and Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic & Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hospitals and Diagnostic Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Biochips Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • PerkinElmer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fluidigm Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Standard BioTools
  • GE Healthcare
  • F. Hoffmann-La Roche AG
  • QIAGEN
  • Randox Laboratories Ltd
  • LI-COR, Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • Arrayit Corporation
  • Nanostring Technologies, Inc.
  • GnuBio, Inc.

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact